Literature DB >> 8384469

Graphic-aided study of metabolic modifications of plasma in cancer using proton magnetic resonance spectroscopy.

J Vion-Dury1, R Favre, M Sciaky, M Kriat, S Confort-Gouny, J R Harlé, N Grazziani, P Viout, F Grisoli, P J Cozzone.   

Abstract

Proton high-resolution MRS of human plasma allows the rapid detection, on the same spectrum, of many compounds originating from different metabolic pathways. In this paper, we illustrate the modifications of the plasma metabolic profiles recorded by proton NMR spectroscopy in different classes of cancers. These modifications can be easily monitored with graphic aids such as 'star plots' which define for each type of cancer a particular pattern describing the most altered metabolic pathways. By using 'star plots' three types of metabolic patterns have been distinguished: (i) the 'inflammatory' pattern characterized by an increase of glycosylated moieties of glycoproteins; (ii) a 'lipid modified' pattern, characterized by various modifications occurring mainly in the lipid moieties detected by MRS; and (iii) a pattern which is often observed in sarcomas and mainly characterized by an alteration in the N-acetyl glucosamine/N-acetyl neuraminic acid ratio. This study demonstrates the ability of proton MRS of plasma to rapidly detect the occurrence of metabolic modifications brought about by cancer evolution or therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384469     DOI: 10.1002/nbm.1940060110

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  2 in total

1.  Assessment of proton magnetic resonance spectroscopy of blood serum as a diagnostic tool in bone marrow transplantation.

Authors:  E Berman; J Kapelushnik; I Sharon; R Or; H Atlan; A Nagler
Journal:  Med Oncol       Date:  1995-06       Impact factor: 3.064

2.  1H NMR ganglioside ceramide resonance region on the differential diagnosis of low and high malignancy of brain gliomas.

Authors:  V Lombardi; L Valko; M Valko; A Scozzafava; H Morris; M Melnik; J Svitel; M Budesinský; J Pelnár; J Steno; T Liptaj; L Zalibera; J Budinská; J Zlatos; A Giuliani; L Mascolo; D Leibfritz; A Troncone; F Marzullo; M Mazur; J Klener; E Zverina
Journal:  Cell Mol Neurobiol       Date:  1997-10       Impact factor: 5.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.